Eterna Therapeutics - Bathi saben saham sajrone rolas wulan pungkasan ERNA

Simbol resmi perusahaan eternatx.com (ERNA)

The mRNA platform market for blood therapies possesses colossal growth potential. The TTM EPS trend for Eterna Therapeutics (ERNA) on the GURU.Markets terminal linear chart contains current data, where the indicator level stands at -17.05. Eterna Therapeutics relies on laboratory partnerships and patent acquisitions; however, the high cost of cellular engineering and the risk of early-stage test failures create financial instability.

ERNA Bathi resik saben siji saham sajrone rolas wulan pungkasan Eterna Therapeutics Inc (28.04.2023 - 16.11.2026)

Rincian analitis lan laporan data perusahaan eternatx.com (ERNA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Ringkesan analitik perusahaan:eternatx.com (ERNA)
Produk sing diprodhuksi Eterna Therapeutics

The metric is calculated as the ratio of total annual net income to the number of common shares. This metric determines the actual efficiency of capital allocation and the sensitivity of profit to operating expenses. For Eterna Therapeutics, which invests in mRNA therapy and cellular engineering, this reflects the cost of R&D developments. The current value of -17.05 demonstrates the business's current profitability. Analyzing the rolling 12-month earnings per share allows for the early identification of liquidity shortage risks.